Jean-Michel M.
- Country
- France
- Department
- Service des Maladies Infectieuses et Tropicales
Research Overview
- Evaluation of Event-Driven Pre-Exposure Prophylaxis with Tenofovir Alafenamide/Emtricitabine for HIV Prevention in Men Who Have Sex with Men in Thailand and France
- Efficacy and Safety of AZD5148 for the Prevention of Recurrent Clostridioides difficile Infection in Adults: A Phase IIb, Randomized, Placebo-Controlled Study
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
Data & Insights
Has run more than one trial at 114 of 248 partner sites.
Specializations
HIV Treatment and Management
The investigator specializes in evaluating novel antiretroviral therapies for treating HIV-1 infection, with particular focus on innovative drug combinations and treatment strategies for both treatment-naïve and experienced patients.
- Novel combination therapies
- Treatment optimization studies
- Long-acting injectable treatments
Areas of interest include evaluation of doravirine-based combinations and integrase inhibitor regimens for advanced HIV infection.
HIV Prevention
The investigator conducts research in HIV pre-exposure prophylaxis (PrEP), exploring both oral and injectable prevention methods for high-risk populations.
- Long-acting preventive treatments
- Event-driven PrEP strategies
- Prevention efficacy studies
Focus includes innovative approaches using lenacapavir and cabotegravir for HIV prevention.
Emerging Infectious Diseases
The investigator studies treatments for COVID-19 and other emerging infections, including monkeypox and Neisseria gonorrhoeae infections.
- Antiviral therapy optimization
- Vaccine development
- Treatment protocols for immunocompromised patients
Research encompasses novel therapeutic approaches and preventive strategies for infectious diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.